![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 17, 2019 5:06:00 PM
Now to the excitement and optimism. This paper is big. It's the beginning. A controlled clinical trial - guess who loves that? FDA. It's the gold standard in pharma and CVSI is acting like a big boy/girl. And as SpaceLady said, they can now write some new indications on their label. Others cannot (if they do, it is false labeling and FDA will ask them to stop). The market just doesn't understand the value of this (yet) because there is a lot of misinformation about CBD and plenty of companies peddling it. The cream will rise to the top, but we didn't see an appropriate price pop. Mentioned it to my wife and she simply said, "maybe the market needs a few days to digest." Hmmm. Wise advice. Part of our problem (oh yeah and MY problem), is that we have these expectations that are perhaps unreasonable. We may be too far from the pivot point for investors to get the significance of this study and this company but I think that day will come. Patience is needed.
Why else be excited? Because Dowling said on Yahoo to expect more announcements like the Kroger one. That's pretty understated but strong. Oh and the drug candidate is progressing. People don't get that this takes time. A lot of tests need to be done, and I am sure they ain't gonna apply unless they're pretty sure of success.
So short time annoyance and frustration I can take because the fundamentals of this company are monstrous, the potential of the sector gynormous, the first mover advantage of CVSI impressive, and the talented leadership team strength all point toward a massively successful company and a commensurate stock valuation. Not today, not tomorrow, but you can't hold this bear down for too much longer.
My advice: if you're an investor, stay patient. If you're a trader, stop griping about what a POS this is, because it is very difficult to day or week trade. Move on to something else.
Happy Monday to all.
MT
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM